Invention Grant
- Patent Title: Tetrazolones as a carboxylic acid bioisosteres
-
Application No.: US15617900Application Date: 2017-06-08
-
Publication No.: US10450280B2Publication Date: 2019-10-22
- Inventor: Matthew Duncton , Rajinder Singh
- Applicant: Rigel Pharmaceuticals, Inc.
- Applicant Address: US CA South San Francisco
- Assignee: Rigel Pharmaceuticals, Inc.
- Current Assignee: Rigel Pharmaceuticals, Inc.
- Current Assignee Address: US CA South San Francisco
- Agency: Bozicevic, Field & Francis LLP
- Agent Rudy J. Ng
- Main IPC: C07D257/04
- IPC: C07D257/04 ; A61K31/41 ; A61K31/4155 ; A61K31/4184 ; A61K31/4245 ; A61K31/4709 ; A61K31/496 ; A61K31/506 ; A61K31/517 ; A61K31/519 ; A61K31/5383 ; A61K31/546 ; A61K31/55 ; A61K31/58 ; C07D403/12 ; C07D471/04 ; C07D498/06 ; C07D401/12 ; A61K31/4725 ; C07D403/10 ; C07D401/14 ; C07D401/04 ; C07D403/04 ; C07D403/06 ; C07D403/14 ; C07D413/10 ; C07D487/04 ; C07D501/46 ; C07J43/00 ; C07D401/10 ; C07D501/16 ; C07J9/00
Abstract:
The present disclosure provides compounds that include a tetrazolone derivative of a carboxyl group of an active agent. This disclosure also relates to pharmaceutical compositions that include these compounds, methods of using these compounds in the treatment of various diseases and disorders, and processes for preparing these compounds.
Public/Granted literature
- US20180002297A1 Tetrazolones as a Carboxylic Acid Bioisosteres Public/Granted day:2018-01-04
Information query
